This inventor holds 4 USPTO granted patents. Top assignee: Cv Therapeutics, Inc.. Active years: 1998-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2004
Title: Suresh Kerwar: Innovator in Proteasome Inhibition
Introduction
Suresh Kerwar is a notable inventor based in West Chester, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for proteasomes. With a total of 4 patents, his work has implications for treating various cell proliferation disorders in mammals.
Latest Patents
Among his latest patents are innovative compositions that include alpha-ketoamide inhibitors of the 20S proteasome. Additionally, he has developed novel indanone compositions that are useful for inhibiting both the 26S and 20S proteasome. These inventions are particularly relevant for addressing cell proliferation disorders, showcasing his commitment to advancing medical science.
Career Highlights
Suresh has worked with prominent companies in the biotechnology sector, including Cv Therapeutics, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in proteasome inhibition.
Collaborations
Throughout his career, Suresh has collaborated with esteemed colleagues such as Robert T. Lum and Steven R. Schow. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Suresh Kerwar's innovative work in proteasome inhibition highlights his role as a significant contributor to biochemistry. His patents and collaborations reflect a dedication to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile